TFAM and cancer: Additionally, they showed that in MEFs and cancer cells treated with the anti-tumoral drug doxorubicin not only damages nDNA, but also directly damages mtDNA, resulting in cytoplasmic release and subsequent cGAS–STING-dependent ISG activation, in a similar way to Tfam depleted cells [57].